HA
HHLR Advisors’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,023,950
| Closed | -$28.1M | – | 50 |
|
|
2024
Q4 | $28.1M | Hold |
1,023,950
| – | – | 0.97% | 16 |
|
|
2024
Q3 | $26.1M | Sell |
1,023,950
-366,703
| -26% | -$9.34M | 0.57% | 18 |
|
|
2024
Q2 | $35.2M | Buy |
1,390,653
+23,164
| +2% | +$587K | 0.87% | 14 |
|
|
2024
Q1 | $42.3M | Sell |
1,367,489
-23,751
| -2% | -$734K | 0.92% | 17 |
|
|
2023
Q4 | $56.2M | Sell |
1,391,240
-1,391,510
| -50% | -$56.2M | 1.13% | 16 |
|
|
2023
Q3 | $73.4M | Sell |
2,782,750
-210,697
| -7% | -$5.56M | 1.64% | 12 |
|
|
2023
Q2 | $51.5M | Sell |
2,993,447
-984,963
| -25% | -$16.9M | 1.1% | 18 |
|
|
2023
Q1 | $66M | Sell |
3,978,410
-1,208,815
| -23% | -$20M | 1.17% | 16 |
|
|
2022
Q4 | $39.5M | Sell |
5,187,225
-174,789
| -3% | -$1.33M | 0.83% | 20 |
|
|
2022
Q3 | $53.3M | Hold |
5,362,014
| – | – | 1.4% | 18 |
|
|
2022
Q2 | $48.7M | Hold |
5,362,014
| – | – | 1.04% | 21 |
|
|
2022
Q1 | $54.4M | Hold |
5,362,014
| – | – | 1.14% | 21 |
|
|
2021
Q4 | $89.4M | Hold |
5,362,014
| – | – | 1.38% | 15 |
|
|
2021
Q3 | $251M | Hold |
5,362,014
| – | – | 3.29% | 9 |
|
|
2021
Q2 | $327M | Hold |
5,362,014
| – | – | 3.36% | 7 |
|
|
2021
Q1 | $330M | Buy |
5,362,014
+650,410
| +14% | +$40.1M | 3.26% | 9 |
|
|
2020
Q4 | $335M | Hold |
4,711,604
| – | – | 2.66% | 10 |
|
|
2020
Q3 | $177M | Hold |
4,711,604
| – | – | 1.34% | 14 |
|
|
2020
Q2 | $154M | Hold |
4,711,604
| – | – | 1.4% | 15 |
|
|
2020
Q1 | $137M | Buy |
4,711,604
+322,914
| +7% | +$9.36M | 1.84% | 15 |
|
|
2019
Q4 | $154M | Hold |
4,388,690
| – | – | 1.92% | 15 |
|
|
2019
Q3 | $94.2M | Buy |
4,388,690
+2,035,790
| +87% | +$43.7M | 1.3% | 20 |
|
|
2019
Q2 | $63.5M | Buy |
+2,352,900
| New | +$63.5M | 1.42% | 21 |
|